UKPPG Bulletin and newsletters
The UKPPG Bulletin is sent to all members every four months, as part of the membership. The current editor is:
Justine Raynsford BPharm MRPharmS
The Mount,
44 Hyde Terrace,
Leeds, LS2 9LN
Tel 0113 305 5530
Fax 0113 305 5533
e-mail jusray9@yahoo.co.uk or justine.raynsford@leedsmh.nhs.uk
Current and back copies (with many thanks to Nina Thomas in Norwich for scanning loads of old copies, and getting bored silly in the process):
2009
2008
2007
2006:
- December 2006, front and back
- May 2006
- January 2006
2005
2004
2003:
2002
Archive
- "What they say is…" David Taylor
- "On anticholinergics" Carol Paton
- "Antipsychotics and cognitive decline" Ann Hutton
- "Can we afford to treat Alzheimer's Disease?" John Donoghue
- Long-term medication review programme and patient education - Diana Jones
- The new generation of "atypical" antipsychotics - Professor John Waddington
- negative symptoms in schizophrenia and their response to antipsychotic medication - Professor Thomas R.E. Barnes
- The first Honorary Life Member of the UKPPG - Margaret Benfield
- Pharmacists and substance abuse - the developing role - Lynn Haygarth
- NICE and atypical antipsychotics - the forgotten side effects, by John Donoghue, August 2002
- Medicinal plants used for psychotropic or behaviour modifying activity by Jonathan Klemens, May 2002
- Local Mental Heath Services in Oxfordshire and how pharmacists are and could be involved in developing services, by Sarah, May 2002
- £2 Million a Year on Mental Health Prescribing: one Trusts approach to improving practice and securing more resources to do it with, by Carol Paton and Geraldine Strathdee, May 2002
- Lilly Schizophrenia Reintegration Awards 2001, by celia Feetam, 2002
- Denise Duncan's invaluable "articles-of-interest" section
Conference reports:
- UKPPG Conference 1997 Abstracts, oral presentations, posters and workshop reports
- Learning Disabilities Study Day, held in Leicester in October 1996
- Learning Disabilities Study Day, held in Leicester in October 1997
Appeals for information:
- Appeals for information from previous editions
It was initially supported by Lederle (for six months), then SmithKline Beecham and publications manager Dee Drinkwater. Pfizer UK Ltd through Hayward Medical Communications then supported it.